Acasti names special advisor
This article was originally published in Scrip
Executive Summary
Laval, Quebec-based Acasti Pharma, an emerging biopharmaceutical company focused on the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies, has named Jerald J Wenker as a special advisor to its board of directors. Mr Wenker – who is currently president and COO of Dermalogica, a skin care company based in the US – has also accepted a nomination for election to serve on Acasti's board at the next annual meeting to be held in 2014.